76 related articles for article (PubMed ID: 22908771)
21. The cost of treatment and follow-up of bladder cancer in Italy.
Racioppi M; Volpe A; Falabella R; Pinto F; Sacco E; Gulino G; D'Agostino D; Bassi PF
Arch Ital Urol Androl; 2007 Sep; 79(3):111-7. PubMed ID: 18041361
[TBL] [Abstract][Full Text] [Related]
22. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
[TBL] [Abstract][Full Text] [Related]
23. Economic costs of excessive alcohol consumption in the U.S., 2006.
Bouchery EE; Harwood HJ; Sacks JJ; Simon CJ; Brewer RD
Am J Prev Med; 2011 Nov; 41(5):516-24. PubMed ID: 22011424
[TBL] [Abstract][Full Text] [Related]
24. Economic costs of overactive bladder in the United States.
Ganz ML; Smalarz AM; Krupski TL; Anger JT; Hu JC; Wittrup-Jensen KU; Pashos CL
Urology; 2010 Mar; 75(3):526-32, 532.e1-18. PubMed ID: 20035977
[TBL] [Abstract][Full Text] [Related]
25. Costs of urinary incontinence and overactive bladder in the United States: a comparative study.
Hu TW; Wagner TH; Bentkover JD; Leblanc K; Zhou SZ; Hunt T
Urology; 2004 Mar; 63(3):461-5. PubMed ID: 15028438
[TBL] [Abstract][Full Text] [Related]
26. Interventional pain management at crossroads: the perfect storm brewing for a new decade of challenges.
Manchikanti L; Singh V; Boswell MV
Pain Physician; 2010; 13(2):E111-40. PubMed ID: 20309388
[TBL] [Abstract][Full Text] [Related]
27. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
28. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
[TBL] [Abstract][Full Text] [Related]
29. Increasing costs of urinary incontinence among female Medicare beneficiaries.
Anger JT; Saigal CS; Madison R; Joyce G; Litwin MS;
J Urol; 2006 Jul; 176(1):247-51; discussion 251. PubMed ID: 16753411
[TBL] [Abstract][Full Text] [Related]
30. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
[TBL] [Abstract][Full Text] [Related]
31. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
[TBL] [Abstract][Full Text] [Related]
32. The current and future burden and cost of overactive bladder in five European countries.
Reeves P; Irwin D; Kelleher C; Milsom I; Kopp Z; Calvert N; Lloyd A
Eur Urol; 2006 Nov; 50(5):1050-7. PubMed ID: 16753252
[TBL] [Abstract][Full Text] [Related]
33. Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007.
Köster I; Huppertz E; Hauner H; Schubert I
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):377-85. PubMed ID: 21264804
[TBL] [Abstract][Full Text] [Related]
34. Economic cost of Guillain-Barré syndrome in the United States.
Frenzen PD
Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
[TBL] [Abstract][Full Text] [Related]
35. Urological diseases cost Americans $11 billion a year, NIH reports.
Hosp Health Netw; 2007 Jun; 81(6):72-3. PubMed ID: 17695171
[No Abstract] [Full Text] [Related]
36. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
37. The medical cost of cardiometabolic risk factor clusters in the United States.
Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
[TBL] [Abstract][Full Text] [Related]
38. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991.
Scitovsky AA; Rice DP
Public Health Rep; 1987; 102(1):5-17. PubMed ID: 3101123
[TBL] [Abstract][Full Text] [Related]
39. The cost of vision loss in Canada. 2. Results.
Cruess AF; Gordon KD; Bellan L; Mitchell S; Pezzullo ML
Can J Ophthalmol; 2011 Aug; 46(4):315-8. PubMed ID: 21816249
[TBL] [Abstract][Full Text] [Related]
40. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
Thompson KM; Tebbens RJ
Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
